Toronto Dominion Bank Ab Cellera Biologics Inc. Transaction History

Toronto Dominion Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$3.91 - $5.93 $546,715 - $829,162	139,825 Added 79900.0%	140,000 $799,000
Q3 2023 Feb 14, 2024	SELL	$4.6 - $7.95 $276,000 - $477,000	-60,000 Reduced 99.71%	175 $0
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $276,000 - $477,000	-60,000 Reduced 99.71%	175 $0
Q2 2023 Feb 14, 2024	SELL	$5.66 - $7.59 $451,809 - $605,871	-79,825 Reduced 57.02%	60,175 $389,000
Q2 2023 Aug 10, 2023	BUY	$5.66 - $7.59 $843 - $1,130	149 Added 0.25%	60,175 $389,000
Q1 2023 May 11, 2023	BUY	$7.31 - $11.18 $408,351 - $624,537	55,862 Added 1341.55%	60,026 $452,000
Q4 2022 Feb 07, 2023	BUY	$9.48 - $14.52 $6,000 - $9,191	633 Added 17.93%	4,164 $42,000
Q3 2022 Nov 09, 2022	BUY	$9.2 - $13.68 $32,485 - $48,304	3,531 New	3,531 $35,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.